Corin
Hip systems including the Trinity acetabular system
- Planning or guidance
- OPS (Optimized Positioning System) patient-specific hip planning
- US status
- Marketed in the US; check the FDA database for specific components
All topics
- What it is
- Who it helps
- Timing
- The procedure
- What a hemiarthroplasty is
- Hemi vs total hip
- Recovery after hip fracture
- Patient journey
- Recovery supplies
- Finding a surgeon
- Insurance and costs
- Questions to ask
- Implant designs
- Side-by-side
- Robotics and navigation
- US manufacturers
- What the evidence says
- Value analysis
- Resources
- Glossary
- References
US market
Hip implant manufacturers in the United States
These companies market total hip replacement systems in the US. Most hip implants reach the market through FDA 510(k) clearance as Class II devices, which is why you'll usually see "FDA cleared" rather than "FDA approved." Clearance means a device is substantially equivalent to an existing one, not that it performs better.
Listed alphabetically. Compiled November 2026 from company pages, FDA records and press releases linked on each card. No company pays to be listed. This list may not be complete and product lines change, so confirm current status in the FDA 510(k) database.
DePuy Synthes (Johnson & Johnson MedTech)
ACTIS and CORAIL stems; PINNACLE acetabular system
- Navigation
- VELYS Hip Navigation; a version with AI-assisted landmark identification became commercially available in the US in June 2026
- US status
- Marketed in the US
Enovis (DJO)
EMPOWR Acetabular and EMPOWR Dual Mobility
- Guidance
- ARVIS augmented-reality headset for hip and knee surgery (not a robot), FDA cleared; commercial launch July 2022
- US status
- Marketed in the US
Exactech
Alteon and Novation hip systems
- US status
- Marketed in the US; check the FDA database for specific components
Medacta
AMIStem and Mpact acetabular system
- Planning or guidance
- MyHip Planner and MyHip Verifier (FDA cleared 2021); NextAR Hip navigation platform with optional smart glasses, 510(k) K252847 cleared January 9, 2026
- US status
- Marketed in the US
Smith+Nephew
POLARSTEM and CATALYSTEM stems; R3 acetabular system; OR3O Dual Mobility
- Guidance
- CORI Surgical System with RI.HIP NAVIGATION (510(k) cleared, announced January 2022); CORIOGRAPH hip pre-op planning (FDA cleared, announced January 2025)
- US status
- Marketed in the US
Stryker
Accolade II and Insignia stems; Trident II acetabular system; MDM Modular Dual Mobility
- Robotics
- Mako SmartRobotics with CT-based Mako Total Hip; Mako 4 and a robotic revision hip application announced March 2025
- US status
- Marketed in the US
Zimmer Biomet
Avenir Complete, Taperloc and Z1 stems; G7 acetabular system, including dual mobility
- Robotics
- ROSA Hip, fluoroscopy-based robotic assistance for direct anterior hip replacement, 510(k) cleared August 2021
- US status
- Marketed in the US
No manufacturers match that filter.